Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer

Journal of the National Cancer Institute

Volumn 94, Issue 14, 2002, Pages 1099-1106

  Chan, June M ^a,b,c   Stampfer, Meir J ^b,c   Ma, Jing ^b   Gann, Peter ^d   Gaziano, J Michael ^e,f   Pollak, Michael ^g   Giovannucci, Edward ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Veterans Administration Boston Health Care System   (United States)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADVANCED CANCER; AGE; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; EARLY CANCER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICAL ANALYSIS;

EID: 0037125383     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.14.1099     Document Type: Article

References (27)

1. Insulin-like growth factors and prostate cancer
2. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
3. The IGF axis in the prostate
4. Insulin-like growth factors and cancer
5. Insulin-like growth factor I: Action and receptor characterization in human prostate cancer cell lines
6. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53 and IGF-independent mechanism
7. Role of the insulin-like growth factor family in cancer development and progression
8. Insulin-like growth factor receptors and binding proteins
9. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
10. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
11. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
12. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
13. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
14. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
15. Insulin-like growth factors and prostate cancer: A population-based case-control study in china
16. IGF-I and prostate cancer
17. Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study
18. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
19. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
20. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF binding protein-3
21. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men
22. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
23. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
24. Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection
25. Serum insulin-like growth factor-1 is not a useful marker of prostate cancer
26. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
27. Low serum insulin-like growth factor 1 (IGF-1): A significant association with prostate cancer